TBC AA-Med Pty Ltd
Product name
TBC
Sponsor
Accepted date
Nov-2023
Active ingredients
toripalimab
Proposed indication
For treatment of adults with nasopharyngeal carcinoma (NPC).
Application type
A (new medicine)
Publication date
Nov-2023
Orphan drug
Sponsors receive a fee waiver to help bring medicines for a small population to market.